Drug Metabolism/Transport and Pharmacokinetics (Record no. 32265)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01897nam a2200133Ia 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220620s9999||||xx |||||||||||||| ||und|| |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9783040000000 |
245 #0 - TITLE STATEMENT | |
Title | Drug Metabolism/Transport and Pharmacokinetics |
546 ## - LANGUAGE NOTE | |
Language note | English[eng] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | tofacitinib||dose-dependent pharmacokinetics||hepatic and intestinal first-pass effect||rats||catalposide||in vitro human metabolism||UDP-glucuronosyltransferase||sulfotransferase||carboxylesterase||celecoxib||drug–drug interaction||fluorescence||HPLC||metabolism||repaglinide||HSG4112||anti-obesity agent||stereoselectivity||pharmacokinetics||compound K||protopanaxadiol (PPD)||biliary excretion||intestinal metabolism||Carthamus tinctorius extract||notoginseng total saponins||comparative pharmacokinetic study||large volume direct injection||compatibility mechanism||mertansine||human hepatocytes||cytochrome P450||UDP-glucuronosyltransferases||sodium-glucose cotransporter 2 (SGLT2) inhibitors||DWP16001||kidney distribution||inhibition mode||diabetes||transporter-enzyme interplay||influx transporter||efflux transporter||physiologically based pharmacokinetic model||cytochrome P450 enzymes||tiropramide||healthy Korean subjects||modeling||population pharmacokinetic||quercetin||breast cancer resistance protein||inhibitor||prazosin||sulfasalazine||kinetic analysis||food–drug interactions||Caco-2||EpiIntestinal||first-pass||P-gp||BCRP||drug transporter||CYP3A4||oral availability||automatization||drug absorption||drug dosing||head-and-neck cancer||real-time measurements||taxanes||tissue engineering||UHPLC-MS/MS||metformin||verapamil||drug interaction||organic cation transporter 2||renal excretion||acute renal failure||gentamicin||cisplatin||hepatic CYP3A1(23)||creatinine clearance||renal clearance||nonrenal clearance |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Song, Im-Sook |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://mdpi.com/books/pdfview/book/4688">https://mdpi.com/books/pdfview/book/4688</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | E-Books |
Withdrawn status | Lost status | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|
Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre | Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre | 20/06/2022 | 20/06/2022 | 20/06/2022 | E-Books |